Trio-Tech International (TRT)
AMEXInformation TechnologySemiconductorsSnapshot 2026-09-04
$10.51+1.55%
Close 2026-09-04 · 1-day change
AMEXInformation TechnologySemiconductorsSnapshot 2026-09-04
Intact: The reason to own it still holds.
Trio-Tech grew revenue 124% in Q3, showing strong demand for testing services. Revenue rose from $15.5M in Q1 to $16.5M in Q3. The company is expanding with new leased space. Management is raising capital to support growth.
The company is loss-making and trades at a very high PE of 146. Margins and cash flow remain weak. The recent 18% selloff shows investor concerns about execution and profitability.
The price is about 10% above our fair value near $8.8. Analysts expect nearly 59% revenue growth, which is ambitious given the company’s loss-making status and recent volatility.
Breaks if: Capital raise fails or proceeds not deployed by 2026-H1
Breaks if: Lease agreement not operational or delayed beyond 2026-H1
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity, as TRT operates in the semiconductor testing sector. The current thesis state is cautious, given the company's loss-making status and the high risk associated with its operations.
The market appears to have priced in a level of fragility, with an expensive valuation compared to peers. However, this valuation is not fully justified given the company's recent performance and the expectations gap of 0.44.
Management is focused on increasing demand for semiconductor testing services, which has shown positive revenue growth. However, the company's recent financial performance has been below its industry peers, indicating potential challenges ahead.
The long-term thesis hinges on several factors, including the company's ability to maintain or improve guidance, the impact of Federal Reserve rate cuts, and the performance of sector leaders like NVDA and TSM. Any unfavorable guidance could lead to a significant negative reaction.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: revenue falls below $15M in any quarter through 2026-Q3
In the next 1 to 3 years, TRT's performance will depend on its execution in a competitive market and external economic factors. Not investment advice.